Archive

Case Report Open Access

Blue Fingernails during Treatment with Cyclophosphamide for Minimal Change Disease: A Very Rare Side Effect

Rollino Cristiana, Giulietta Beltrame, Roberta Fenoglio, Michela Ferro, Paola Mesiano, Giacomo Quattrocchio and Dario Roccatello
Clin Med Rev Case Rep Volume 4, Issue 3

Abstract: We present the case of a 52-year-old lady affected with cortico dependent minimal change disease who developed a blue pigmentation of her fingernails during a 3-months treatment with cyclophosphamide for cortico dependent minimal change disease. The typical manifestation of onset of Minimal Change Disease (MCD) is a pure nephrotic syndrome.

PDF   | Full Text   DOI: 10.23937/2378-3656/1410162

Case Report Open Access

Extubation Airway Emergency after Spinal Fusion Using Bone Morphogenetic Protein

Bradley J Scherer, Brian D Benneyworth, Mara E Nitu and Brian D Lelan
Clin Med Rev Case Rep Volume 4, Issue 3

Abstract: An 11-year-old female who was admitted to the pediatric intensive care unit (PICU) intubated and mechanically ventilated with severe traumatic brain injury and occipito-cervical dislocation following a high speed motor vehicle collision, underwent both posterior arthrodesis from occiput to C3 and open reduction of cranio-cervical dislocation on hospital day 7.

PDF   | Full Text   DOI: 10.23937/2378-3656/1410161

Case Report Open Access

Two Cases of Pseudomalabsorption Treated Successfully with Parenteral Levothyroxine

Seher Cetinkaya Altuntas, Mehtap Evran, Murat Sert and Tamer Tetiker
Clin Med Rev Case Rep Volume 4, Issue 3

Abstract: Hypothyroidism is a frequently seen endocrine disorder which may be managed by levothyroxine (LT4) replacement in most of the patients. Some patients with hypothyroidism do not respond and are refractory to oral LT4 therapy. The most encountered causes of unresponsiveness to oral LT4 replacement comprise non-compliance with therapy and malabsorption.

PDF   | Full Text   DOI: 10.23937/2378-3656/1410160

Original Review Open Access

Anesthetic Management of Traumatic Brain Injury

Hashim Qureshi, Hussain Mithaiwala, Jacob Ezell and Marco Maurtua
Clin Med Rev Case Rep Volume 4, Issue 3

Abstract: Worldwide, Traumatic Brain Injury (TBI) is a leading cause of morbidity and mortality. It is the third most common cause of injury related death with direct and indirect costs totaling an estimated 60 billion dollars annually in the United States. Management of a TBI patient is guided by recommendations made by the Brain Trauma Foundation (BTF).

PDF   | Full Text   DOI: 10.23937/2378-3656/1410159

Volume 4
Issue 3